BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $116.63M in the quarter ending March 31, 2025, a decrease of -44.76%. This brings the company's revenue in the last twelve months to $127.42M, down -41.71% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

• Revenue (ttm): $127.42M
• Revenue Growth: -41.71%
• P/S Ratio: 61.88
• Revenue / Employee: $174,541
• Employees: 730
• Market Cap: 7.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	221.90M	212.60M	2,285.27%
Dec 31, 2023	9.30M	-68.35M	-88.02%
Dec 31, 2022	77.65M	7.93M	11.38%
Dec 31, 2021	69.72M	61.47M	745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.